A 2 year prospective study to evaluate the onset of action of Mavenclad in subjects with highly active relapsing Multiple Sclerosis - CONVERIS Research Information System by Thomson Reuters:

Title: A 2 year prospective study to evaluate the onset of action of Mavenclad in subjects with highly active relapsing Multiple Sclerosis

Funder
Cardiff & Vale University Health Board

Principal Investigator

Project Details

Net value award figure for Cardiff University: £6,162.00

Start date: 17/09/2018

End date: 31/12/2021